English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51192115    Online Users :  762
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"ann lii cheng"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 406-415 of 690  (69 Page(s) Totally)
<< < 36 37 38 39 40 41 42 43 44 45 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-08-31T06:29:49Z High serum transforming growth factor-�]1 levels predict outcome in hepatocellular carcinoma patients treated with sorafenib Lin T.-H.; Shao Y.-Y.; Chan S.-Y.; Huang C.-Y.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:49Z The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; Cheng W.-F.; ANN-LII CHENG; Yang J.C.H.; Lai M.-S.
臺大學術典藏 2021-08-31T06:29:48Z Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart Chang C.; Lin C.-H.; ANN-LII CHENG; Medeiros L.J.; Chang K.-C.
臺大學術典藏 2021-08-31T06:29:48Z Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-08-31T06:29:48Z Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study ANN-LII CHENG; Kang Y.-K.; He A.R.; Lim H.Y.; Ryoo B.-Y.; Hung C.-H.; Sheen I.-S.; Izumi N.; Austin T.; Wang Q.; Greenberg J.; Shiratori S.; Beckman R.A.; Kudo M.
臺大學術典藏 2021-08-31T06:29:47Z The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases Chiang Y.; Yang J.C.-H.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Lin Z.-Z.; Lan K.-H.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏 2021-08-31T06:29:47Z The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; Lan K.-H.; Chen C.-H.; Yu H.-J.; Lai M.-K.; ANN-LII CHENG; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H.
臺大學術典藏 2021-08-31T06:29:47Z Young patients with colorectal cancer have increased risk of second primary cancers Liang Y.-H.; Shao Y.-Y.; Chen H.-M.; Lai C.-L.; Lin Z.-Z.; Kuo R.N.; ANN-LII CHENG; Yeh K.-H.; Lai M.-S.
臺大學術典藏 2021-08-31T06:29:46Z Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; ANN-LII CHENG; Shih T.T.-F.
臺大學術典藏 2021-08-31T06:29:46Z Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma ANN-LII CHENG; Thongprasert S.; Lim H.Y.; Sukeepaisarnjaroen W.; Yang T.-S.; Wu C.-C.; Chao Y.; Chan S.L.; Kudo M.; Ikeda M.; Kang Y.-K.; Pan H.; Numata K.; Han G.; Balsara B.; Zhang Y.; Rodriguez A.-M.; Zhang Y.; Wang Y.; Poon R.T.P.

Showing items 406-415 of 690  (69 Page(s) Totally)
<< < 36 37 38 39 40 41 42 43 44 45 > >>
View [10|25|50] records per page